Related Experiment Video
Updated: Feb 19, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MicroRNA-186 suppresses lung cancer progression by targeting SIRT6
Libo Ruan1,2,3, Jun Chen2, Litao Ruan4
1Faculty of Environmental Science and Engineering, Kunming University of Science and Technology, Yunnan, China.
Abstract:
MicroRNAs are a class of small non-coding RNA molecules that play crucial roles in the initiation and progression of lung cancer. This study was undertaken to investigate the expression and roles of miR-186 in lung cancer. Ectopic expression experiments demonstrated that miR-186 functions as a tumor suppressor. Bioinformatic predictions, a luciferase reporter assay, and protein expression analysis suggested that miR-186 could inhibit the protein levels of SIRT6, a purported tumor suppressor gene. Collectively, our results indicated that miR-186 could inhibit lung cancer progression through targeting SIRT6 and that miR-186 may be a therapeutic target for lung cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Experimental RNAi
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Abnormal Proliferation

